[HTML][HTML] The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs
K Hadiloo, S Taremi, SH Safa, S Amidifar… - Pharmacological …, 2024 - Elsevier
Cancer treatment is one of the fundamental challenges in clinical setting, especially in
relapsed/refractory malignancies. The novel immunotherapy-based treatments bring new …
relapsed/refractory malignancies. The novel immunotherapy-based treatments bring new …
Mechanoimmunology in the solid tumor microenvironment
The tumor microenvironment (TME) is a complex and dynamic ecosystem that adjoins the
cancer cells within solid tumors and comprises distinct components such as extracellular …
cancer cells within solid tumors and comprises distinct components such as extracellular …
Melanoma-associated fibroblasts in tumor-promotion flammation and antitumor immunity: novel mechanisms and potential immunotherapeutic strategies
Q Zhou, X Jin, Y Zhao, Y Wang, M Tao… - Human Molecular …, 2024 - academic.oup.com
Melanoma, renowned for its aggressive behavior and resistance to conventional treatments,
stands as a formidable challenge in the oncology landscape. The dynamic and complex …
stands as a formidable challenge in the oncology landscape. The dynamic and complex …
Interferon-Gamma Secretion Is Significantly Decreased in Stage III Breast Cancer Patients
JI Yi, J Schneider, ST Lim, B Park, YJ Suh - International Journal of …, 2024 - mdpi.com
Even though some studies have shown possible clinical relationship between molecular
subtypes and tumor infiltrating natural killer (NK) cells around tumors, there are few studies …
subtypes and tumor infiltrating natural killer (NK) cells around tumors, there are few studies …
CAR-T IMMUNOTHERAPY—RECENT ADVANCES AND CURRENT CHALLENGES IN CANCER TREATMENT: A REVIEW.
J RONOWICZ-PILARCZYK - Acta Poloniae Pharmaceutica, 2024 - search.ebscohost.com
Adoptive cell therapy represents a modern immunotherapeutic approach utilizing immune
cells as dynamic agents against cancer cells, often called “living drugs”. In recent times …
cells as dynamic agents against cancer cells, often called “living drugs”. In recent times …
Gut microbiota in colorectal cancer: The importance of Parvimonas micra
T Löwenmark - 2024 - diva-portal.org
Colorectal cancer (CRC) is a heterogenous disease consisting of multiple molecular
subtypes, each of which has diverse treatment responses and prognoses. The importance of …
subtypes, each of which has diverse treatment responses and prognoses. The importance of …
[引用][C] Magnetic nanoparticles: An emerging nanomedicine for cancer immunotherapy
P Jungcharoen, J Panaampon, T Imemkamon… - 2024 - Elsevier